• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.94% Nasdaq Down 1.70%

    Vanda Pharmaceuticals, Inc. (VNDA)

    -NasdaqGM
    12.02 Down 0.18(1.48%) 11:56AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:12.20
    Open:12.09
    Bid:12.00 x 700
    Ask:12.02 x 400
    1y Target Est:26.67
    Beta:2
    Earnings Date:Feb 11 - Feb 16 (Est.)
    Day's Range:11.91 - 12.21
    52wk Range:8.34 - 19.25
    Volume:475,100
    Avg Vol (3m):811,747
    Market Cap:407.49M
    P/E (ttm):N/A
    EPS (ttm):-1.68
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    VNDADown 1.48%407.49M
    AZNUp 1.74%90.68B
    LLYDown 0.67%76.62B
    JNJDown 0.95%283.52B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):9.49
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.63
    Quarterly EPS Est (Dec-14) :-0.20
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):-0.47

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Vanda Pharmaceuticals Inc., a biopharmaceutical company, is engaged in the development and commercialization of pharmaceutical products. Its product portfolio includes HETLIOZ, a product for the treatment of Non-24-Hour Sleep-Wake Disorder; Fanapt... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback